{"entity":{"type":"insider","cik":"0001574579","url":"/insider/0001574579","json_url":"/insider/0001574579.json","name":"Svoronos Dawn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":17,"first":"2015-03-04","last":"2023-08-24","span_basis":"filed_date"},"name_variants":[{"name":"Svoronos Dawn","source":"filing","n_filings":17,"first_seen":"2015-03-04","last_seen":"2023-08-24"}],"transactions":[{"id":8670906,"accession":"0000950170-23-044403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-044403","line_url":"/filing/0000950170-23-044403#line-1","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":38.7,"price_display":"38.70","price_state":"stated","total_value":967500.0,"total_display":"967,500.00","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-24","scope":"insider"},{"id":7922023,"accession":"0001209191-23-028882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028882","line_url":"/filing/0001209191-23-028882#line-1","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"ACELYRIN, Inc.","issuer_ticker":"SLRN","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":270000.0,"total_display":"270,000.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-11","scope":"insider"},{"id":6944878,"accession":"0000899243-22-023597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-023597","line_url":"/filing/0000899243-22-023597#line-1","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1908.0,"shares_display":"1,908","price_per_share":27.2446,"price_display":"27.24","price_state":"stated","total_value":51982.6968,"total_display":"51,982.70","shares_owned_after":5376.0,"shares_owned_after_display":"5,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-22","scope":"insider"},{"id":6665966,"accession":"0001415889-22-006410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-006410","line_url":"/filing/0001415889-22-006410#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":27.201,"price_display":"27.20","price_state":"stated","total_value":20074.338,"total_display":"20,074.34","shares_owned_after":29017.0,"shares_owned_after_display":"29,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-10","scope":"insider"},{"id":6925043,"accession":"0001209191-22-030075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-030075","line_url":"/filing/0001209191-22-030075#line-1","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.8526,"price_display":"0.85","price_state":"stated","total_value":25578.0,"total_display":"25,578.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6445557,"accession":"0001179110-22-000392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-22-000392","line_url":"/filing/0001179110-22-000392#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510.0,"shares_display":"510","price_per_share":38.525,"price_display":"38.52","price_state":"stated","total_value":19647.75,"total_display":"19,647.75","shares_owned_after":26555.0,"shares_owned_after_display":"26,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":5132120,"accession":"0000899243-21-025001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-025001","line_url":"/filing/0000899243-21-025001#line-2","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1609.0,"shares_display":"1,609","price_per_share":36.54,"price_display":"36.54","price_state":"stated","total_value":58792.86,"total_display":"58,792.86","shares_owned_after":3684.0,"shares_owned_after_display":"3,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"},{"id":5512178,"accession":"0001179110-21-006598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-006598","line_url":"/filing/0001179110-21-006598#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365.0,"shares_display":"365","price_per_share":41.885,"price_display":"41.88","price_state":"stated","total_value":15288.025,"total_display":"15,288.02","shares_owned_after":27065.0,"shares_owned_after_display":"27,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":5042348,"accession":"0001209191-21-024310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-024310","line_url":"/filing/0001209191-21-024310#line-1","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":10.0169,"price_display":"10.02","price_state":"stated","total_value":200338.0,"total_display":"200,338.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-01","scope":"insider"},{"id":5542454,"accession":"0001179110-21-001091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-001091","line_url":"/filing/0001179110-21-001091#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":506.0,"shares_display":"506","price_per_share":56.956,"price_display":"56.96","price_state":"stated","total_value":28819.736,"total_display":"28,819.74","shares_owned_after":27430.0,"shares_owned_after_display":"27,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider"},{"id":3195322,"accession":"0000899243-20-017315","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-017315","line_url":"/filing/0000899243-20-017315#line-3","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663.0,"shares_display":"1,663","price_per_share":63.6881,"price_display":"63.69","price_state":"stated","total_value":105913.3103,"total_display":"105,913.31","shares_owned_after":3137.0,"shares_owned_after_display":"3,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-19","scope":"insider"},{"id":3195320,"accession":"0000899243-20-017315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017315","line_url":"/filing/0000899243-20-017315#line-2","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":881.0,"shares_display":"881","price_per_share":64.4154,"price_display":"64.42","price_state":"stated","total_value":56749.9674,"total_display":"56,749.97","shares_owned_after":2256.0,"shares_owned_after_display":"2,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-19","scope":"insider"},{"id":2956905,"accession":"0001070081-20-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001070081-20-000110","line_url":"/filing/0001070081-20-000110#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364.0,"shares_display":"364","price_per_share":48.36,"price_display":"48.36","price_state":"stated","total_value":17603.04,"total_display":"17,603.04","shares_owned_after":26286.0,"shares_owned_after_display":"26,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider"},{"id":4127622,"accession":"0001171843-17-005101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-17-005101","line_url":"/filing/0001171843-17-005101#line-1","is_derivative":false,"issuer_cik":"0001574579","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001574579","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.8154,"price_display":"2.82","price_state":"stated","total_value":140770.0,"total_display":"140,770.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-15","scope":"insider"},{"id":4607574,"accession":"0001070081-17-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001070081-17-000088","line_url":"/filing/0001070081-17-000088#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":13.4892,"price_display":"13.49","price_state":"stated","total_value":337230.0,"total_display":"337,230.00","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-23","filed_date":"2017-05-24","scope":"insider"},{"id":2177813,"accession":"0001209191-16-108887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-108887","line_url":"/filing/0001209191-16-108887#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":38.9,"price_display":"38.90","price_state":"stated","total_value":233400.0,"total_display":"233,400.00","shares_owned_after":18234.0,"shares_owned_after_display":"18,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":8301641,"accession":"0001209191-15-069835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-069835","line_url":"/filing/0001209191-15-069835#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":89.15,"price_display":"89.15","price_state":"stated","total_value":276365.0,"total_display":"276,365.00","shares_owned_after":12117.0,"shares_owned_after_display":"12,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-08","scope":"insider"},{"id":8338602,"accession":"0001209191-15-022702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-022702","line_url":"/filing/0001209191-15-022702#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001574579","owner_name":"Svoronos Dawn","owner_url":"/insider/0001574579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3350.0,"shares_display":"3,350","price_per_share":119.7502,"price_display":"119.75","price_state":"stated","total_value":401163.17,"total_display":"401,163.17","shares_owned_after":13639.0,"shares_owned_after_display":"13,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001582313","name":"Xenon Pharmaceuticals Inc.","url":"/issuer/0001582313","role":"Director","n_filings":2,"first_seen":"2017-08-15","last_seen":"2023-08-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001962918","name":"ACELYRIN, Inc.","url":"/issuer/0001962918","role":"Director","n_filings":1,"first_seen":"2023-05-11","last_seen":"2023-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Director","n_filings":3,"first_seen":"2020-06-19","last_seen":"2022-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Director","n_filings":6,"first_seen":"2017-05-24","last_seen":"2022-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Adverum Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Director","n_filings":2,"first_seen":"2021-04-01","last_seen":"2022-05-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001011835","name":"MEDIVATION, INC.","url":"/issuer/0001011835","role":"Director","n_filings":3,"first_seen":"2015-03-04","last_seen":"2016-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001574579","retrieved_at":"2026-08-21T20:14:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}